UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (date of earliest event reported): May 6, 2011
Commission File No. 001-12575
UTAH MEDICAL PRODUCTS, INC. |
(Exact name of Registrant as specified in its charter) |
| |
| |
UTAH | 87-0342734 |
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
| |
| |
| |
7043 South 300 West |
Midvale, Utah 84047 |
Address of principal executive offices |
Registrant's telephone number: (801) 566-1200
ITEM 5.07. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
On May 6, 2011 at the annual meeting, shareholders of the Company approved or indicated their preference on the following matters submitted to them for consideration:
Elected Ernst G. Hoyer as a director of the Company: | |
For 2,644,531 | Withheld 90,998 | Broker Non-Votes 544,656 | |
| | | |
Elected James H. Beeson as a director of the Company: | | |
For 2,652,244 | Withheld 83,285 | Broker Non-Votes 544,656 | |
| | | |
Ratified the selection of Jones, Simkins P.C. as the Company’s independent public accounting firm for the year ended December 31, 2011: |
For 3,244,036 | Against 14,717 | Abstentions 21,432 | |
| | | |
Approved, on an advisory basis, the compensation paid to UTMD’s named executive officers, including the Compensation Discussion and Analysis, compensation tables and narrative discussion: |
For 2,697,042 | Against 25,619 | Abstentions 12,868 | |
| | | |
Indicated, on an advisory basis, their preference for annual shareholder votes on executive compensation: |
1 Year 2,367,054 | 2 Year 44,313 | 3 Year 293,886 | Abstentions 30,277 |
Pursuant to the requirements of the Securities Exchanges Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| UTAH MEDICAL PRODUCTS, INC. |
| REGISTRANT |
| |
| |
Date: 5/10/2011 | By: /s/ Kevin L. Cornwell |
| Kevin L. Cornwell |
| CEO |